Status:
COMPLETED
Effect of Introperative Ketamine and Lidocaine Infusion on Postoperative Opioid Consumption in Posterior Spinal Fusion Surgery
Lead Sponsor:
Ataturk University
Conditions:
Spine Fusion
Postoperative Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Objective: The primary aim of this study was to investigate the effect of ketamine and lidocaine on postoperative opioid consumption in posterior spinal fusion surgery. Materials and Methods: Ethics ...
Eligibility Criteria
Inclusion
- between the ages of 18-65, who have an ASA (American Society of Anesthesiologists) risk classification I-II-III
Exclusion
- Previous spinal surgery, Morbid obesity (BMI\> 35 kg / m2), Lidocaine, ketamine or opioid allergy. Severe cardiac or pulmonary disease, Liver or kidney dysfunction Poorly controlled hypertension, Substance abuse, Chronic opioid use, Pregnancy, Psychiatric disorder, Cognitive impairment History of stroke, head injury, and intracranial mass or bleeding and patients who did not want to participate in the study were excluded from the study.
Key Trial Info
Start Date :
May 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04711668
Start Date
May 29 2019
End Date
December 30 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atatürk University
Erzurum, Turkey (Türkiye), 25100